Crossmark

Thrombopoietin-based CAR-T cells demonstrate in vitro and in vivo cytotoxicity to MPL positive acute myelogenous leukemia and hematopoietic stem cells

Crossref DOI link: https://doi.org/10.1038/s41434-021-00283-5

Published Online: 2021-08-13

Published Print: 2022-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zoine, Jaquelyn T. https://orcid.org/0000-0001-7914-4610
Prince, Chengyu

Story, Jamie Y.

Branella, Gianna M. https://orcid.org/0000-0003-3025-7977
Lytle, Allison M.

Fedanov, Andrew

Alexander, Jordan S.

Porter, Christopher C.

Doering, Christopher B.

Spencer, H. Trent

Chandrakasan, Shanmuganathan https://orcid.org/0000-0001-8007-9932
Funding

Funding for this research was provided by:

U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (1K08HL141635-01A1)

U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12HD072245)
License Information

Text and Data Mining valid from 2021-08-13

Version of Record valid from 2021-08-13
More Information

Article History

Received: 27 July 2020

Revised: 10 July 2021

Accepted: 21 July 2021

First Online: 13 August 2021

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below